サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1386501

脳腫瘍診断市場レポート：2030年までの動向、予測、競合分析

Brain Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

脳腫瘍診断市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月11日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

脳腫瘍診断の動向と予測

世界の脳腫瘍診断市場は、2024年から2030年までのCAGRが23.7%で、2030年までに推定93億米ドルに達すると予想されています。この市場の主な促進要因は、脳腫瘍患者の増加、脳腫瘍の早期診断に対する意識の高まり、脳腫瘍細胞に関連するドラッグデリバリーシステムの革新です。世界の脳腫瘍診断市場の将来は、病院、専門クリニック、診断センター・研究機関、外来手術センター市場におけるビジネスチャンスで有望視されています。

脳腫瘍診断市場の洞察

Lucintelの予測では、生活習慣、遺伝的要因、診断システムの改善といった病因論的動向により、多形膠芽腫が引き続き最大セグメントとなります。

同市場では、脳腫瘍の増加、病院インフラの改善、がん診断への投資と資金調達の増加により、病院が予測期間中に最も高い成長を遂げると予測されます。

北米は、研究開発活動の活発化とイメージング技術の向上により、引き続き最大セグメントです。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の脳腫瘍診断市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の脳腫瘍診断市場動向（2018～2023年）と予測（2024～2030年）
  • 検査タイプ別の世界の脳腫瘍診断市場
    • 画像検査
    • 生検
    • 腰椎穿刺
    • 分子検査
    • 脳波検査
    • その他
  • がんタイプ別の世界の脳腫瘍診断市場
    • 聴神経腫
    • 星状細胞腫
    • 多形膠芽腫
    • 髄膜腫
    • 希突起膠腫
    • その他
  • 年齢層別の世界の脳腫瘍診断市場
    • 子供
    • 大人
    • 老人
  • 最終用途別の世界の脳腫瘍診断市場
    • 病院
    • 専門クリニック
    • 診断センターおよび調査機関
    • 外来手術センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の脳腫瘍診断市場
  • 北米の脳腫瘍診断市場
  • 欧州の脳腫瘍診断市場
  • アジア太平洋脳腫瘍診断市場
  • その他地域脳腫瘍診断市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 検査タイプ別の世界の脳腫瘍診断市場の成長機会
    • がんタイプ別の世界の脳腫瘍診断市場の成長機会
    • 年齢層別の世界の脳腫瘍診断市場の成長機会
    • 最終用途別の世界の脳腫瘍診断市場の成長機会
    • 地域別の世界の脳腫瘍診断市場の成長機会
  • 世界の脳腫瘍診断市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の脳腫瘍診断市場の能力拡大
    • 世界の脳腫瘍診断市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Thermo Fisher Scientific
  • Siemens Healthcare Diagnostics
  • Hologic
  • NantOmics
  • GE Healthcare
  • NIHON KOHDEN
  • Canon
  • FUJIFILM Holdings
目次

Brain Cancer Diagnostic Trends and Forecast

The future of the global brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets. The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030 with a CAGR of 23.7% from 2024 to 2030. The major drivers for this market are the increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.

A more than 150-page report is developed to help in your business decisions.

Brain Cancer Diagnostic by Segment

The study includes a forecast for the global brain cancer diagnostic by test type, cancer type, age group, end use, and region.

Brain Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Imaging Test
  • Biopsy
  • Lumber Puncture
  • Molecular Testing
  • Electroencephalography
  • Others

Brain Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

  • Acoustic Neuroma
  • Astrocytomas
  • Glioblastoma Multiforme
  • Meningiomas
  • Oligodendroglioma
  • Others

Brain Cancer Diagnostic Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Children
  • Adult
  • Geriatic

Brain Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers & Research Institutes
  • Ambulatory Surgical Centers
  • Others

Brain Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Brain Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain cancer diagnostic companies profiled in this report include-

  • Thermo Fisher Scientific
  • Siemens Healthcare Diagnostics
  • Hologic
  • Nantomics
  • GE Healthcare
  • Nihon Kohden
  • Canon
  • Fujifilm Holdings

Brain Cancer Diagnostic Market Insights

Lucintel forecasts that glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and improved diagnostic systems.

Within this market, hospitals is expected to witness highest growth over the forecast period due to increasing prevelance of brain cancer, improvement in the hospital infrastructure, and rising investments and funding in cancer daignostics.

North America will remain the largest segment due to increasing research and development activities and improved imaging techniques in the region.

Features of the Global Brain Cancer Diagnostic Market

Market Size Estimates: Brain cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Brain cancer diagnostic market size by various segments, such as by test type, cancer type, age group, end use, and region in terms of ($B).

Regional Analysis: Brain cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, cancer types, age groups, end uses, and regions for the brain cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the brain cancer diagnostic market size?

Answer: The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030.

Q.2 What is the growth forecast for brain cancer diagnostic market?

Answer: The global brain cancer diagnostic market is expected to grow with a CAGR of 23.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the brain cancer diagnostic market?

Answer: The major drivers for this market are the increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.

Q4. What are the major segments for brain cancer diagnostic market?

Answer: The future of the brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets.

Q5. Who are the key brain cancer diagnostic market companies?

Answer: Some of the key brain cancer diagnostic companies are as follows:

  • Thermo Fisher Scientific
  • Siemens Healthcare Diagnostics
  • Hologic
  • Nantomics
  • GE Healthcare
  • Nihon Kohden
  • Canon
  • Fujifilm Holdings

Q6. Which brain cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and improved diagnostic systems.

Q7. In brain cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment due to increasing research and development activities and improved imaging techniques in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the brain cancer diagnostic market by test type (imaging test, biopsy, lumber puncture, molecular testing, electroencephalography, and others), cancer type (acoustic neuroma, astrocytomas, glioblastoma multiforme, meningiomas, oligodendroglioma, and others), age group (children, adult, and geriatic), end use (hospitals, specialty clinics, diagnostic centers & research institutes, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Brain Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Brain Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Brain Cancer Diagnostic Market by Test Type
    • 3.3.1: Imaging Test
    • 3.3.2: Biopsy
    • 3.3.3: Lumber Puncture
    • 3.3.4: Molecular Testing
    • 3.3.5: Electroencephalography
    • 3.3.6: Others
  • 3.4: Global Brain Cancer Diagnostic Market by Cancer Type
    • 3.4.1: Acoustic Neuroma
    • 3.4.2: Astrocytomas
    • 3.4.3: Glioblastoma Multiforme
    • 3.4.4: Meningiomas
    • 3.4.5: Oligodendroglioma
    • 3.4.6: Others
  • 3.5: Global Brain Cancer Diagnostic Market by Age Group
    • 3.5.1: Children
    • 3.5.2: Adult
    • 3.5.3: Geriatic
  • 3.6: Global Brain Cancer Diagnostic Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Specialty Clinics
    • 3.6.3: Diagnostic Centers & Research Institutes
    • 3.6.4: Ambulatory Surgical Centers
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Brain Cancer Diagnostic Market by Region
  • 4.2: North American Brain Cancer Diagnostic Market
    • 4.2.2: North American Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
  • 4.3: European Brain Cancer Diagnostic Market
    • 4.3.1: European Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
    • 4.3.2: European Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Brain Cancer Diagnostic Market
    • 4.4.1: APAC Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
    • 4.4.2: APAC Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Brain Cancer Diagnostic Market
    • 4.5.1: ROW Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
    • 4.5.2: ROW Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Test Type
    • 6.1.2: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Cancer Type
    • 6.1.3: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Age Group
    • 6.1.4: Growth Opportunities for the Global Brain Cancer Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Brain Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Brain Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Siemens Healthcare Diagnostics
  • 7.3: Hologic
  • 7.4: NantOmics
  • 7.5: GE Healthcare
  • 7.6: NIHON KOHDEN
  • 7.7: Canon
  • 7.8: FUJIFILM Holdings